Due to its irreversible inhibition of GABA-T, the clinical effects of vigabatrin may outlast drug half-life, and is determined by the time required to synthesize new enzyme. Therapeutic and toxic ...

For this reason, it contains a boxed warning. Xcorpi (cenobamate) is a newer antiepileptic drug that is FDA-approved to treat ...

The first in a new class of treatment for uncontrolled ... Fycompa (perampanel) is the first and only licensed anti-epileptic drug to selectively target AMPA receptors, a protein in the brain ...

Dr Reddy's and Lupin are recalling drugs in the US due to labelling and manufacturing errors, respectively, according to the ...

Over the past 15 years, several new antiepileptic drugs (AEDs) have become available for the treatment of childhood epilepsy. No objective evidence currently exists to indicate that these new AEDs ...

Valproate, one of the most commonly prescribed antiepileptic medications, has been associated in the past with birth defects and developmental problems. However, two newer drugs – levetiracetam and ...

A recent study by scientists at Queen Mary University of London looked at a possible link between some commonly used seizure ...

As per its latest Enforcement Report, USFDA said a US-based subsidiary of the Hyderabad-based drug major is recalling certain ...

The new MHRA guidance places AEDs into three ... Generic substitution for brand name antiepileptic drugs: a survey. Can J Neurol Sci 2000; 27:37–43. 5. Epilepsy mortality and risk factors ...

Eslicarbazepine: systemic exposure to antiepileptic drugs is increased in patients with mild-to-moderate renal impairment. The dose of eslicarbazepine should be reduced in patients with a ...

On the hunt for informative health and disease biomarkers, researchers increasingly turn to the combinatorial power of new technologies and multiomics strategies. Meet the low-cost standard for ...